These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2235818)

  • 21. Ursodeoxycholic acid in the treatment of chronic liver disease.
    Cirillo NW; Zwas FR
    Am J Gastroenterol; 1994 Sep; 89(9):1447-52. PubMed ID: 8079918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic active hepatitis in the elderly.
    Selby CD; Toghill PJ
    Age Ageing; 1986 Nov; 15(6):350-6. PubMed ID: 3799364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute seronegative autoimmune hepatitis.
    Ozaslan E; Samsar U; Erden E
    Hepatogastroenterology; 2010; 57(98):334-5. PubMed ID: 20583438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporin, a new treatment for autoimmune chronic active hepatitis.
    Mistilis SP; Vickers CR; Darroch MH; McCarthy SW
    Med J Aust; 1985 Nov; 143(10):463-5. PubMed ID: 4088113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of combination therapy of vitamin K1 and ursodeoxycholic acid on liver function tests.
    Iijima T; Nambu M
    Trop Gastroenterol; 1988; 9(3):139-44. PubMed ID: 3194959
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study.
    Manzillo G; Piccinino F; Sagnelli E; Izzo CM; Pasquale G; Maio G; Filippini P; Felaco FM
    Ric Clin Lab; 1983; 13(2):261-8. PubMed ID: 6622929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
    Lirussi F; Okolicsanyi L
    Ital J Gastroenterol; 1992 Jan; 24(1):31-5. PubMed ID: 1571577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting.
    Neuberger J; Portmann B; Calne R; Williams R
    Transplantation; 1984 Apr; 37(4):363-5. PubMed ID: 6369666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of autoimmune hepatitis.
    Johnson PJ
    Gut; 1997 Jul; 41(1):3-4. PubMed ID: 9274462
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of cyclosporine-sensitive, steroid-resistant, autoimmune chronic active hepatitis.
    Person JL; McHutchison JG; Fong TL; Redeker AG
    J Clin Gastroenterol; 1993 Dec; 17(4):317-20. PubMed ID: 8308220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of autoimmune hepatitis in primary biliary cirrhosis.
    Gossard AA; Lindor KD
    Liver Int; 2007 Oct; 27(8):1086-90. PubMed ID: 17845536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis.
    Jackson LD; Song E
    Gut; 1995 Mar; 36(3):459-61. PubMed ID: 7698710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid.
    Güldütuna S; Leuschner U; Imhof M; Zimmer G
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():49-54. PubMed ID: 1449017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life-saving immunosuppressive treatment in severe autoimmune chronic active hepatitis.
    Maggiore G; Bernard O; Hadchouel M; Alagille D
    J Pediatr Gastroenterol Nutr; 1985 Aug; 4(4):655-8. PubMed ID: 4032180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
    Kanzler S; Gerken G; Dienes HP; Meyer zum Büschenfelde KH; Lohse AW
    Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune hepatitis in Japan: trends in a nationwide survey.
    Takahashi A; Arinaga-Hino T; Ohira H; Torimura T; Zeniya M; Abe M; Yoshizawa K; Takaki A; Suzuki Y; Kang JH; Nakamoto N; Fujisawa T; Yonemoto K; Tanaka A; Takikawa H;
    J Gastroenterol; 2017 May; 52(5):631-640. PubMed ID: 27722997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis.
    Hegarty JE; Nouri Aria KT; Portmann B; Eddleston AL; Williams R
    Hepatology; 1983; 3(5):685-9. PubMed ID: 6618435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis.
    McFarlane IG; Hegarty JE; McSorley CG; McFarlane BM; Williams R
    Lancet; 1984 Oct; 2(8409):954-6. PubMed ID: 6149344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Hay JE; Rakela J
    Mayo Clin Proc; 1990 Jan; 65(1):23-30. PubMed ID: 2296210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis and cholestasis in a middle-aged woman.
    Perrillo RP; Mason AL; Jacob S; Gerber MA
    Hepatology; 1996 Sep; 24(3):730-4. PubMed ID: 8781350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.